Is Covid-19 a new Hematologic Disease ?

Benjamin Debuc, David M Smadja

Abstract
SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus
disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis
leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community
to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or
stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to
choose appropriate treatment strategies.
Keywords SARS-CoV-2 . Covid-19 . Coagulopathy . D-dimers . Lymphopenia . Mesenchymal stem cells . Cytokine .
Inflammation . Thrombosis . Stemcells

Cliquer sur le lien suivant pour lire l’article

https://www.lab-recherchecarpentier.com/wp-content/uploads/2020/06/article-Debuc-et-al-SCRR-2020.pdf

Donnez votre avis